Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Harsha Engineers: Growth Surge Continues! Analyst Reveals ₹407 Target – Hold or Sell?

Brokerage Reports

|

Updated on 11 Nov 2025, 08:02 am

Whalesbook Logo

Reviewed By

Simar Singh | Whalesbook News Team

Short Description:

Harsha Engineers International reported a 7.3% year-on-year revenue increase and improved EBITDA margins to 14.1%. The company benefited from strong export demand, with its Romania unit growing 38% YoY. The Advantek facility is set to boost domestic prospects, and the bronze bushings segment anticipates ~30% revenue growth. Prabhudas Lilladher maintains a 'Hold' rating, raising the target price to Rs 407 from Rs 402.
Harsha Engineers: Growth Surge Continues! Analyst Reveals ₹407 Target – Hold or Sell?

▶

Stocks Mentioned:

Harsha Engineers International

Detailed Coverage:

Harsha Engineers International demonstrated a steady financial performance, with revenue growing by 7.3% year-on-year and its EBITDA margin expanding by 228 basis points to 14.1%. This improvement was largely driven by robust export momentum, reflecting a sustained recovery in industrial demand across European and other key markets. The company's Romania unit was a strong performer, reporting a significant 38% year-on-year growth in Q2 FY26, supported by a favorable product mix of finished goods.

The operational greenfield facility, Advantek, is expected to strengthen the company's domestic prospects. Furthermore, management anticipates increasing wallet share from existing clients, which is projected to drive approximately 30% revenue growth in the bronze bushings segment for FY26. The management maintains a cautiously optimistic outlook, guiding for high single-digit growth in its consolidated business and low to mid-teen growth specifically within its India-Engineering segment.

Valuation and Outlook: Harsha Engineers International is currently trading at a Price-to-Earnings (P/E) ratio of 20.2x for FY27 estimated earnings and 18.0x for FY28 estimated earnings. Prabhudas Lilladher has rolled forward its valuation to September 2027 estimates and maintained its 'Hold' rating. The stock is valued at a P/E of 20x September 2027 estimated earnings (previously 21x March 2027 estimated earnings), leading to a revised target price of Rs 407, up from the previous Rs 402.

Impact: This research report provides crucial insights into Harsha Engineers International's recent performance, future growth drivers, and analyst expectations. The 'Hold' recommendation and revised target price can significantly influence investor sentiment and trading decisions for the stock. Investors often use such reports to assess the stock's current valuation and future potential.

Rating: 7/10

Difficult Terms: * **YoY (Year-on-Year)**: A comparison of a financial metric against the same period in the previous year (e.g., Q2 FY26 vs Q2 FY25). * **EBITDA margin**: A profitability ratio representing profit as a percentage of revenue after deducting operating expenses but before accounting for interest, taxes, depreciation, and amortization. It indicates operational efficiency. * **bps (basis points)**: A unit of measure equal to one-hundredth of one percent (0.01%). 228 bps equals 2.28%. * **Greenfield facility**: A new facility built from the ground up on an undeveloped site, implying new capacity and operations. * **Bronze bushings**: Cylindrical components made of bronze, used as bearings to reduce friction between moving parts in machinery. * **P/E (Price-to-Earnings ratio)**: A common stock valuation metric that compares the company's current share price to its earnings per share. A higher P/E generally suggests investors expect higher earnings growth in the future. * **FY27E / FY28E**: Fiscal Year 2027 Estimated / Fiscal Year 2028 Estimated. These are projections of the company's financial performance for those fiscal years. * **Sep’27E / Mar’27E**: Earnings estimates for the period ending September 2027 and March 2027, respectively. * **TP (Target Price)**: The price level at which an analyst or brokerage firm expects a stock to trade within a specified future period.


Healthcare/Biotech Sector

Neuberg Diagnostics IPO Blast! $350 Million Dream IPO Coming to India's Red Hot Market?

Neuberg Diagnostics IPO Blast! $350 Million Dream IPO Coming to India's Red Hot Market?

Torrent Pharma: Buy Signal Issued! Rs 4200 Target & Strategic JB Chemicals Deal Unveiled!

Torrent Pharma: Buy Signal Issued! Rs 4200 Target & Strategic JB Chemicals Deal Unveiled!

Neuberg Diagnostics IPO Blast! $350 Million Dream IPO Coming to India's Red Hot Market?

Neuberg Diagnostics IPO Blast! $350 Million Dream IPO Coming to India's Red Hot Market?

Torrent Pharma: Buy Signal Issued! Rs 4200 Target & Strategic JB Chemicals Deal Unveiled!

Torrent Pharma: Buy Signal Issued! Rs 4200 Target & Strategic JB Chemicals Deal Unveiled!


Stock Investment Ideas Sector

UTI Fund Manager's Secret: Ditch the Hype, Invest in Value for BIG Long-Term Gains!

UTI Fund Manager's Secret: Ditch the Hype, Invest in Value for BIG Long-Term Gains!

UTI Fund Manager's Secret: Ditch the Hype, Invest in Value for BIG Long-Term Gains!

UTI Fund Manager's Secret: Ditch the Hype, Invest in Value for BIG Long-Term Gains!